Clinical Research
Thermo Fisher Scientific Awards Oncomine Clinical Research Grants to Advance Global Oncology Diagnostics
Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosi...
September 12, 2024 | News
HighTide Therapeutics Presents Promising Data on HTD1801 for Type 2 Diabetes at EASD 2024
HighTide Therapeutics, Inc. (2511.HK), a clinical-stage biopharmaceutical company dedicated to developing multifunctional therapies for chronic liver and m...
September 12, 2024 | News
Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue
Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...
September 12, 2024 | News
Avistone Biotechnology Presents Promising Clinical Results of Dual c-MET and EGFR Inhibitors for NSCLC at WCLC 2024
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
MGI Introduces CycloneSEQ-WT02 and CycloneSEQ-WY01, Advancing High-Throughput Nanopore Sequencing
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global r...
September 10, 2024 | Product Spotlight
Neurophet Expands Global Reach with AI Brain Imaging Partnership and Research Recognition
Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis Neurophet, an artificial intelligence (AI) solution ...
September 10, 2024 | News
Janssen-Cilag International Announces Superior Long-Term Outcomes of Amivantamab Plus Lazertinib from MARIPOSA Study
Janssen-Cilag International NV, a Johnson & Johnson company, announced new longer follow-up data from the landmark Phase 3 MARIPOSA study. These ...
September 09, 2024 | News
Daiichi Sankyo and AstraZeneca’s Datopotamab Deruxtecan Shows Superior Progression-Free Survival in Biomarker-Positive NSCLC Patients
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in p...
September 09, 2024 | News
Merck Launches Global Phase III Trial of Oral Cladribine for Generalized Myasthenia Gravis Treatment
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG) Cl...
September 06, 2024 | News
Crucial Data Solutions Unveils AI-Powered Module to Revolutionize Clinical Trial Data Analysis
Crucial Data Solutions, a leading provider of data collection and trial management software to advance clinical research, has announced the launch of...
September 06, 2024 | News
Vetter’s Rankweil Site Expands as Project Orders Surge, Completing First 100 Aseptic Batches
An increase in project orders drives further site growth The first 100 aseptic batches at Vetter’s Rankweil site predict a successful future The ...
September 06, 2024 | News
Regenity Biosciences Secures NMPA Approval for Matrixflex™ Collagen Dental Membrane in China
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced it has received regulatory ap...
September 05, 2024 | News
Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology
Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...
September 04, 2024 | News
Merck Initiates Phase III MyClad Trial Dosing First Patient in Study of Oral Cladribine for Generalized Myasthenia Gravis
Merck, a leading science and technology company, announced the first patient has been dosed in the Phase III MyClad trial (NCT06463587) evaluating the effi...
August 30, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
